KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 129 filers reported holding KEROS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,435,443 | -19.8% | 421,438 | +1.1% | 1.28% | -2.8% |
| Q2 2023 | $16,748,229 | -34.0% | 416,830 | -29.8% | 1.31% | -42.5% |
| Q1 2023 | $25,362,263 | -10.8% | 593,964 | +0.3% | 2.28% | -13.5% |
| Q4 2022 | $28,447,624 | +26.4% | 592,412 | -1.0% | 2.64% | +15.9% |
| Q3 2022 | $22,505,000 | +36.1% | 598,213 | -0.0% | 2.28% | +18.4% |
| Q2 2022 | $16,532,000 | -53.8% | 598,333 | -9.1% | 1.92% | -39.1% |
| Q1 2022 | $35,790,000 | +10.8% | 658,145 | +19.2% | 3.16% | +36.5% |
| Q4 2021 | $32,303,000 | +371.4% | 552,098 | +218.7% | 2.31% | +412.9% |
| Q3 2021 | $6,852,000 | – | 173,210 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |